Therapeutic targeting of MLL leukemia. Several key molecular functions that may provide potential therapeutic targets in MLL leukemia include chromatin association by the MLL portion of chimeric oncoproteins, nucleation of transcriptional effector complexes through the fusion partner moiety of MLL chimeras, downstream mediators of MLL, and pathways known to cooperate with MLL.